Influence of the arterial blood pressure and nonhemodynamic factors on left ventricular hypertrophy in moderate essential hypertension
Abstract
In a group of 36 untreated patients with mild to moderate essential hypertension (office systolic and diastolic blood pressures (BPs) 160 +/- 3.4 and 102 +/- 1.5 mm Hg, respectively), a 24-hour ambulatory BP monitoring and determination of left ventricular (LV) mass index according to the formula of Devereux were performed. After an overnight fast, blood samples were taken for the determination of serum aldosterone, plasma renin activity and serum parathyroid hormone. Urinary catecholamines were sampled for 24 hours. LV mass index (143.7 +/- 8 g/m2) did not correlate significantly either with office systolic or diastolic BP. The correlation of LV mass index with mean 24-hour systolic BP (145 +/- 3 mm Hg) was statistically significant: r = 0.395, p = 0.026. However, the best correlation was obtained with mean 24-hour diastolic BP (90 +/- 3 mm Hg) with r = 0.500 (p = 0.004). Urinary catecholamines were not correlated with LV mass index. LV mass index correlated significantly with plasma renin activity (r = 0.346, p = 0.050), and aldosterone (r = 0.559, p = 0.001). There was a very significant correlation between LV mass index and parathyroid hormone (r = 0.719, p = 0.00001) even after adjustment for mean 24-hour systolic and diastolic BPs. These results clearly demonstrate that ambulatory BP determinants but not office BP parameters are well correlated with LV hypertrophy in essential hypertension. Nonhemodynamic factors are important determinants of LV mass as well. Besides the renin-angiotensin-aldosterone system, parathyroid hormone appears to play an important role in cardiac hypertrophy.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The development of LVH has been attributed to many factors, including raised arterial pressure levels and growth-promoting substances such as angiotensin II, insulin-like growth factor-1 and circulating catecholamines.
“The development of LVH has been attributed to many factors, including raised arterial pressure levels (resulting in increased myocardial workload) and growth-promoting substances such as angiotensin II, insulin-like growth factor-1 and circulating catecholamines (5–10).”
From Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive (2001) · cites this paper as [6]
Cites
Sahn, D. J., DeMaria, A. N., KISSLO, J. A., & Weyman, A. E. (1978) · Circulation · doi:10.1161/01.cir.58.6.1072 · Cited by 7,430 · see citing works
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699 · see citing works
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.
Devereux, R. B., & Reichek, N. (1977) · Circulation · doi:10.1161/01.cir.55.4.613 · Cited by 4,499 · see citing works
Devereux, R. B., Pickering, T. G., Harshfield, G. A., Kleinert, H. D., Denby, L., Clark, L. A., Pregibon, D., Jason, M., Kleiner, B., BORER, J. S., et al. (1983) · Circulation · doi:10.1161/01.cir.68.3.470 · Cited by 666 · see citing works
Cardiac hypertrophy. Mechanical, neural, and endocrine dependence.
Morgan, H. E., & Baker, K. M. (1991) · Circulation · doi:10.1161/01.cir.83.1.13 · Cited by 619 · see citing works
Calcium-Regulating Hormones in Essential Hypertension
Resnick, L. M., MÜLLER, F. B., & LARAGH, J. H. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-5-649 · Cited by 371 · see citing works
Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects.
Savage, D. D., Drayer, J. I. M., Henry, W. L., Mathews, E. C., Ware, J. H., Gardin, J. M., Cohen, E., Epstein, S. E., & Laragh, J. H. (1979) · Circulation · doi:10.1161/01.cir.59.4.623 · Cited by 365 · see citing works
Effect of parathyroid hormone on rat heart cells.
BOGIN, E., Massry, S. G., & Harary, I. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110137 · Cited by 333 · see citing works
McCarron, D. A., Pingree, P. A., Rubin, R. J., Gaucher, S. M., Molitch, M., & Krutzik, S. R. (1980) · Hypertension · doi:10.1161/01.hyp.2.2.162 · Cited by 324 · see citing works
BP as a Determinant of Cardiac Left Ventricular Muscle Mass
Drayer, J. I. M. (1983) · Archives of Internal Medicine · doi:10.1001/archinte.1983.00350010094016 · Cited by 211 · see citing works
Devereux, R. B., Savage, D. D., Drayer, J. I. M., & Laragh, J. H. (1982) · Hypertension · doi:10.1161/01.hyp.4.4.524 · Cited by 124 · see citing works
Determinants of left ventricular hypertrophy and function in hypertensive patients
ABI‐SAMRA, F. M., Fouad, F. M., & Tarazi, R. C. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90114-6 · Cited by 117 · see citing works
Parathyroid Hormone as a Smooth Muscle Relaxant*
Mok, L. L. S., Nickols, G. A., Thompson, J. C., & COOPER, C. W. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-4-420 · Cited by 115 · see citing works
Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism--an association.
Symons, C., Fortune, F., Greenbaum, R. A., & Dandona, P. (1985) · Heart · doi:10.1136/hrt.54.5.539 · Cited by 82 · see citing works
Grobbee, D. E., Hackeng, W. H. L., Birkenhäger, J. C., & Hofman, A. (1988) · BMJ · doi:10.1136/bmj.296.6625.814 · Cited by 60 · see citing works
Left ventricular hypertrophy, cardiac diseases and hypertension: Recent experiences
Frohlich, E. D. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90001-6 · Cited by 34 · see citing works
Pearce, P. C., HAWKEY, C. M., Symons, C., & Olsen, E. G. J. (1985) · Heart · doi:10.1136/hrt.54.4.420 · Cited by 33 · see citing works
Epidemiologic Considerations in Defining Hypertension
Roccella, E. J., Bowler, A. E., & Horan, M. J. (1987) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30808-2 · Cited by 26 · see citing works
Cardiac Effects of Angiotensin Antagonists in Normotensive Rats
Sen, S., Tarazi, R. C., & Bumpus, F. M. (1979) · Clinical Science · doi:10.1042/cs0560439 · Cited by 24 · see citing works
Adrenergic nervous system and left ventricular mass in primary hypertension
Ferrara, L. A., MANCINI, M., SIMONE, G. D., Pisanti, N., Capone, D., Fasano, M. L., & MANCINI, M. (1989) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059416 · Cited by 23 · see citing works
Quantitation of catecholamines in urine and in plasma
Moerman, E. J., & Schaepdryver, A. D. (1984) · Clinica Chimica Acta · doi:10.1016/0009-8981(84)90279-1 · Cited by 21 · see citing works
Cardiac hypertrophy in hypertension
Tarazi, R. C., & Dunbar, J. B. (1983) · Raven Press eBooks · Cited by 16 · see citing works
Gelmann, E. (1982) · Archives of Internal Medicine · doi:10.1001/archinte.142.1.90 · Cited by 13 · see citing works
hm, R. O. B., van Baak, M. A., van Hooff, M. E., Mooy, J., & Rahn, K. H. (1987) · Journal of Hypertension · doi:10.1097/00004872-198712000-00004 · Cited by 11 · see citing works
Pathogenesis of Sodium and Water Retention
Muñoz, S. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906083202319 · Cited by 10 · see citing works
Parathyroid origin of a new hypertensive factor
Pang, P. K. T., Kaneko, T., & Lewanczuk, R. Z. (1990) · Experimental Gerontology · doi:10.1016/0531-5565(90)90062-7 · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
Lonn, E., Yusuf, S., Jha, P., Montague, T. J., Teo, K. K., Benedict, C. R., & Pitt, B. (1994) · Circulation · doi:10.1161/01.cir.90.4.2056 · Cited by 503 · see citing works
Mirza, M. A. I., Larsson, A. O., Melhus, H., Lind, L., & Larsson, T. E. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.013 · Cited by 341 · see citing works
Primary hyperparathyroidism and heart disease ? a review
ANDERSSON, P., Rydberg, E., & Willenheimer, R. B. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.07.010 · Cited by 302 · see citing works
Parathyroid hormone and left ventricular hypertrophy
Saleh, F. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.09.010 · Cited by 247 · see citing works
Pitt, B. (1995) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00877755 · Cited by 203 · see citing works
Walton, K. G., Pugh, N. D. C., Gelderloos, P., & Macrae, P. (1995) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.1995.1.263 · Cited by 163 · see citing works
Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive
Greenwood, J. P., Scott, E. M., Stoker, J. B., & Mary, D. A. S. G. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01600-x · Cited by 161 · see citing works
Beneficial Effects of Calcimimetics on Progression of Renal Failure and Cardiovascular Risk Factors
Ogata, E., Ritz, E., Odoni, G., Amann, K., & Orth, S. R. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000056188.23717.e5 · Cited by 149 · see citing works
Prediction of Cardiac Structure and Function by Repeated Clinic and Ambulatory Blood Pressure
Fagard, R. H., Staessen, J. A., & Thijs, L. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.22 · Cited by 143 · see citing works
Duprez, D. A., Bauwens, F. R., De Buyzere, M. L., De Backer, T. L., Kaufman, J. M., Van Hoecke, J., Vermeulen, A., & Clement, D. L. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90240-d · Cited by 139 · see citing works
Self-citationKupari, M. M., Koskinen, P., & Virolainen, J. (1994) · Circulation · doi:10.1161/01.cir.89.3.1041 · Cited by 123 · see citing works
Burns, J., Sivananthan, M. U., Ball, S. G., Mackintosh, A. F., Mary, D. A. S. G., & Greenwood, J. P. (2007) · Circulation · doi:10.1161/circulationaha.106.668863 · Cited by 122 · see citing works
Diagnosis of mild hypertension by ambulatory blood pressure monitoring.
Weber, M. A., Neutel, J. M., Smith, D. H. G., & Graettinger, W. F. (1994) · Circulation · doi:10.1161/01.cir.90.5.2291 · Cited by 120 · see citing works
Akmal, M., Barndt, R., Ansari, A. N., Mohler, J. G., & Massry, S. G. (1995) · Kidney International · doi:10.1038/ki.1995.18 · Cited by 101 · see citing works
Khattar, R. S., Acharya, D. U., Kinsey, C., Senior, R., & Lahiri, A. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715070-00005 · Cited by 95 · see citing works
Aldosterone: Cardiovascular assault
Struthers, A. D. (2002) · American Heart Journal · doi:10.1067/mhj.2002.129969 · Cited by 85 · see citing works
Fagard, R. H., Staessen, J. A., Thijs, L., & Amery, A. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00043-o · Cited by 70 · see citing works
Sympathetic overactivity in hypertension: A risk factor for cardiovascular disease
Palatini, P. (2001) · Current Hypertension Reports · doi:10.1007/s11906-001-0065-z · Cited by 68 · see citing works
Cellular Ions in NIDDM: Relation of Calcium to Hyperglycemia and Cardiac Mass
Barbagallo, M., Gupta, R. K., & Resnick, L. M. (1996) · Diabetes Care · doi:10.2337/diacare.19.12.1393 · Cited by 60 · see citing works
Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality
Kaplinsky, E. (1994) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00877223 · Cited by 45 · see citing works
Altered cytosolic calcium homeostasis in rat cardiac myocytes in CRF
Zhang, Y., Smogorzewski, M. J., Ni, Z., & Massry, S. G. (1994) · Kidney International · doi:10.1038/ki.1994.148 · Cited by 45 · see citing works
Nakahara, T., Takata, Y., Hirayama, Y., Asano, K., Adachi, H., Shiokawa, G., Sumi, T., Ogawa, T., & Yamashina, A. (2007) · Circulation Journal · doi:10.1253/circj.71.716 · Cited by 44 · see citing works
Novo, S. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00127-1 · Cited by 44 · see citing works
Martínez-Vea, A., Valero, F. A., Bardajı́, A., Gutiérrez, C., Broch, M., Garcia, C., Richart, C., & Oliver, J. A. (2000) · American Journal of Nephrology · doi:10.1159/000013583 · Cited by 43 · see citing works
Sihm, I., Schroeder, A. P., Aalkjær, C., Holm, M., Mosrn, B., Mulvany, M. J., Thygesen, K. A., & Lederballe, O. (1995) · Blood Pressure · doi:10.3109/08037059509077602 · Cited by 41 · see citing works
Early signals after stretch leading to cardiac hypertrophy. Key role of NHE-1
Horacio, E. C. (2008) · Frontiers in bioscience · doi:10.2741/3213 · Cited by 40 · see citing works
Iwashima, Y., Horio, T., Kuroda, S., Takishita, S., & Kawano, Y. (2002) · Hypertension Research · doi:10.1291/hypres.25.49 · Cited by 40 · see citing works
Moon, K. H., Song, I. S., Yang, W. S., Shin, Y. T., Kim, S. B., Song, J. K., & Park, J. S. (2000) · American Journal of Nephrology · doi:10.1159/000013625 · Cited by 39 · see citing works
Blood pressure load determines left ventricular mass in essential hypertension
Bauwens, F. R., Duprez, D., Buyzere, M. D., & Clement, D. L. (1992) · International Journal of Cardiology · doi:10.1016/0167-5273(92)90032-x · Cited by 36 · see citing works
Self-citationReversibility of left ventricular hypertrophy by antihypertensive drugs
Fagard, R. (1995) · The Netherlands Journal of Medicine · doi:10.1016/0300-2977(95)00064-t · Cited by 34 · see citing works
Almendral, J. L., Shick, V., Rosendorff, C., & Atlas, S. A. (2010) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2010.02.007 · Cited by 33 · see citing works
Duprez, D., Buyzere, M. D., Backer, T. L. M. D., & Clement, D. L. (1994) · Blood Pressure · doi:10.3109/08037059409102292 · Cited by 33 · see citing works
Self-citationErythrocyte ion fluxes in essential hypertensive patients with left ventricular hypertrophy.
Sierra, À., Coca, A., Paré, J. C., Sánchez, M., Valls, V., & Urbano-Márquez, A. (1993) · Circulation · doi:10.1161/01.cir.88.4.1628 · Cited by 32 · see citing works
Aldosterone Inhibits the Fetal Program and Increases Hypertrophy in the Heart of Hypertensive Mice
Azibani, F., Devaux, Y., Coutance, G., Schlossarek, S., Polidano, E., Fazal, L., Merval, R., Carrier, L., Solal, A. C., Chatziantoniou, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038197 · Cited by 29 · see citing works
Palatini, P., Majahalme, S. K., Amerena, J. V., Nesbitt, S. D., Vriz, O., Michieletto, M., Krause, L. C., & Julius, S. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018060-00016 · Cited by 27 · see citing works
Schroeder, A. P. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00352-5 · Cited by 26 · see citing works
Hypertensive Left Ventricular Hypertrophy: Pathophysiology, Assessment and Treatment
Otterstad, J. E., Smiseth, O. A., & Kjeldsen, S. E. (1996) · Blood Pressure · doi:10.3109/08037059609062101 · Cited by 24 · see citing works
Effects of Antihypertensive Agents on the Left Ventricle
ez, J. D., lez, A. G., pez, B. A. L., Ravassa, S., & o, M. A. A. F. (2001) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200101040-00005 · Cited by 22 · see citing works
Yoshida, C., Goda, A., Naito, Y., Nakaboh, A., Matsumoto, M., Otsuka, M., Ohyanagi, M., Hirotani, S., Lee‐Kawabata, M., Tsujino, T., et al. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834103d4 · Cited by 22 · see citing works
Schneider, R. H., Castillo-Richmond, A., Alexander, C. N., Myers, H. F., Kaushik, V., Aranguri, C., Norris, K. C., Haney, C., Rainforth, M. V., Calderon, R., et al. (2001) · Behavioral Medicine · doi:10.1080/08964280109595775 · Cited by 21 · see citing works
McCarty, M. F. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.12.054 · Cited by 19 · see citing works
Phillips, R. A., & Diamond, J. A. (1999) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(99)70019-8 · Cited by 16 · see citing works
Ferrari, R., Ceconi, C., Curello, S., Pepi, P., Mazzoletti, A., & Visioli, O. (1996) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00052511 · Cited by 14 · see citing works
Role of ACE inhibitors in hypertension with left ventricular hypertrophy
Richards, M., Nicholls, M. G., & Crozier, I. (1994) · Heart · doi:10.1136/hrt.72.3_suppl.s24 · Cited by 11 · see citing works
Duprez, D. A., Buyzere, M. D., PAELINCK, M., Rubens, R., Dhooge, W., & Clement, D. L. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917110-00012 · Cited by 11 · see citing works
Self-citationNew concepts regarding events that lead to myocardial infarction
Opie, L. H. (1995) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00877858 · Cited by 11 · see citing works
McCarty, M. F., Barroso-Aranda, J., & Contreras, F. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.12.023 · Cited by 10 · see citing works
Hypertension and Left Ventricular Hypertrophy: Is Drug Therapy Beneficial?
Eselin, J. A., & Carter, B. L. (1994) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1994.tb02790.x · Cited by 10 · see citing works
Duprez, D. A., Buyzere, M. L. D., Backer, T. L. M. D., Kaufman, J. M., Hoecke, M. J. V., Vermeulen, A., & Cement, D. L. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90807-o · Cited by 10 · see citing works
Self-citationAldosterone, a New Appreciation of Its Role in Heart Failure
Cha, A. J., Malecha, S. E., & Judge, K. W. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.13.1107.35023 · Cited by 10 · see citing works
Helvacı, A., Copur, B., & Adaş, M. (2012) · Balkan Medical Journal · doi:10.5152/balkanmedj.2012.097 · Cited by 9 · see citing works
Cingolani, H. E., Pérez, N. G., Caldiz, C. I., Garciarena, C. D., Giusti, V. C. D., Correa, M. V., Villa‐Abrille, M. C., Yeves, A. M., Ennis, I. L., de Cingolani, G. C., et al. (2009) · Springer eBooks · doi:10.1007/978-90-481-2850-1_13 · Cited by 8 · see citing works
Kamycheva, E., Wilsgaard, T., Schirmer, H., & Jorde, R. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs210 · Cited by 7 · see citing works
Role of MicroRNA-93 I in Pathogenesis of Left Ventricular Remodeling via Targeting Cyclin-D1
Zhang, J., Qin, L., Han, L., Zhao, Y., Jing, H., Song, W., & Shi, H. (2017) · Medical Science Monitor · doi:10.12659/msm.897542 · Cited by 7 · see citing works
Diamond, J. A., & Phillips, R. A. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-0258-5.50114-9 · Cited by 7 · see citing works
Shi, H., Chu, H., Lv, Z., Qi, G., Guo, J., Fu, W., Wang, X., Guo, X., Ge, J., & Yin, C. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4119 · Cited by 5 · see citing works
Assaad, S. N., El-Aghoury, A. A., Elsharkawy, E. M., Elsherbiny, T. M., & Osman, A. A. (2017) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2017.10.002 · Cited by 4 · see citing works
Jespersen, B., Brock, A., Charles, P., Danielsen, H., Sørensen, S. S., & Pedersen, E. B. (1993) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365519309092543 · Cited by 4 · see citing works
Belastungsblutdruck und linksventrikuläre Hypertrophie
Ketelhut, R. G., & Franz, I.-W. (1993) · Springer eBooks · doi:10.1007/978-3-642-77975-6_17 · Cited by 4 · see citing works
Kravez, E. B., Идрисова, Е. М., Damdindorsh, D., & Латыпова, В. Н. (2009) · Clinical and experimental thyroidology · doi:10.14341/ket20095245-50 · Cited by 3 · see citing works
Gottdiener, J. S. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3640-1.50038-1 · Cited by 3 · see citing works
Робертович, В. В., Павловна, Р. М., Копина, М. Н., Zhmajlova, S. V., Шматько, Д. П., & Prozorova, I. V. (2008) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2008-4-4-28-31 · Cited by 2 · see citing works
HYPERPARATIROSIS AND CARDIOVASCULAR SYSTEM PATHOLOGY
Voronenko, I. V., Al, S., Rozhinskaya, L. Y., & Mel'nichenko, G. A. (2006) · Osteoporosis and Bone Diseases · doi:10.14341/osteo2006233-41 · Cited by 3 · see citing works
Барсуков, А. В., Kazantsev, V. A., Сергеевна, Т. М., Nikolayev, A. V., & Kurganova, T. A. (2005) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2005-11-3-166-172 · Cited by 1 · see citing works
Сыволап, В. В., & Novikov, E. V. (2019) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2019.1.155792 · Cited by 1 · see citing works
Mineralisation of precardiac transplantation patients: A key role for parathormone
Oberlin, F., Rozenberg, S., Guillemant, J., Dorent, R., Maistre, G., Gandjbakhch, I., Guillemant, S., & Bourgeois, P. (1994) · Journal of Bone and Mineral Metabolism · doi:10.1007/bf02375685 · Cited by 1 · see citing works
Cardiac function in primary and secondary hyperparathyroidism
Näppi, S. E. (2001) · Tampere University Institutional Repository (Tampere University)
Jokiniitty, J. M. (2002) · Tampere University Institutional Repository (Tampere University)
Role for aldosterone in cardiovascular injury
Perlstein, T. S., Oestreicher, E. M., & Adler, G. K. (2003) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200306000-00006
Bauwens, F. R., Duprez, D., Buyzere, M. D., & Buyzere, D. L. (1992) · International Journal of Cardiology · doi:10.1016/0167-5273(92)90144-r
Self-citation
- Authors
- Bauwens, F. R., Duprez, D. A., De Buyzere, M. L., De Backer, T. L., Kaufman, J. M., Van Hoecke, J., Vermeulen, A., & Clement, D. L.
- Affiliations
- Ghent University Hospital (BE)
- Corresponding author
- Duprez, Daniel A.
- ORCID
- Vermeulen, Alex
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 1991-10
- Volume
- 68
- Issue
- 9
- Pages
- 925-929
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W1981369013
- Cited by
- 70
- References
- 26
- Citations by year
- 2019: 1 · 2017: 3 · 2013: 1 · 2012: 2
- FWCI
- 5.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- left ventricular hypertrophy, essential hypertension, ambulatory blood pressure, 24-hour ambulatory blood pressure, left ventricular mass index, plasma renin activity, aldosterone, parathyroid hormone, urinary catecholamines, renin-angiotensin-aldosterone system
- MeSH terms
- Adult, Aldosterone, Blood Pressure, Blood Pressure Determination, Epinephrine, Female, Cardiomegaly, Humans, Hypertension, Male, Middle Aged, Norepinephrine, Parathyroid Hormone, Renin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review